About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study Of Ispinesib In Subjects With Breast Cancer

NCT00089973·13 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

GlaxoSmithKline

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Stage IIIB or Stage IV breast cancer
Previously received anthracycline and taxane therapy

You may not be if

Actively receiving anti-cancer therapy agent(s).

The record

StatusCompleted

PhasePhase 2

Taking part50

StartedJun 2004

UpdatedFeb 26, 2018

Conditions

Neoplasms, Breast

Where13

GSK Investigational Site
Jacksonville, Florida, United States
GSK Investigational Site
Indianapolis, Indiana, United States
GSK Investigational Site
Chapel Hill, North Carolina, United States

Clareo Health | Study Of Ispinesib In Subjects With Breast Cancer